Terminal glycosylation of cystic fibrosis airway epithelial cells
- PMID: 11294504
- DOI: 10.1023/a:1007156014384
Terminal glycosylation of cystic fibrosis airway epithelial cells
Abstract
Cystic fibrosis (CF) has a characteristic glycosylation phenotype usually expressed as a decreased ratio of sialic acid to fucose. The glycosylation phenotype was found in CF/T1 airway epithelial cells (deltaF508/deltaF508). When these cells were transfected and were expressing high amounts of wtCFTR, as detected by Western blot analysis and in situ hybridization, the cell membrane glycoconjugates had an increased sialic acid content and decreased fucosyl residues in alpha1,3/4 linkage to antennary N-acetyl glucosamine (Fuc(alpha)1,3/4GlcNAc). After the expression of wtCFTR decreased, the amount of sialic acid and Fuc(alpha)1,3/4GlcNAc returned to levels shown by the parent CF cells. Sialic acid was measured by chemical analysis and Fuc(alpha)1,3/4GlcNAc was detected with a specific alpha1,3/4 fucosidase. CF and non-CF airway cells in primary culture also had a similar reciprocal relationship between fucosylation and sialylation. It is possible that the glycosylation phenotype is involved in the pathogenesis of CF lung disease by facilitating bacterial colonization and leukocyte recruitment.
Similar articles
-
Terminal glycosylation in cystic fibrosis (CF): a review emphasizing the airway epithelial cell.Glycoconj J. 2001 Sep;18(9):649-59. doi: 10.1023/a:1020815205022. Glycoconj J. 2001. PMID: 12386452 Review.
-
Terminal glycosylation and disease: influence on cancer and cystic fibrosis.Glycoconj J. 2000 Jul-Sep;17(7-9):617-26. doi: 10.1023/a:1011034912226. Glycoconj J. 2000. PMID: 11421353 Review.
-
Activity of fucosyltransferases and altered glycosylation in cystic fibrosis airway epithelial cells.Biochimie. 2001 Aug;83(8):743-7. doi: 10.1016/s0300-9084(01)01323-2. Biochimie. 2001. PMID: 11530206
-
Alpha1,3fucosyltransferases in cystic fibrosis airway epithelial cells.Biochimie. 2003 Mar-Apr;85(3-4):363-7. doi: 10.1016/s0300-9084(03)00061-0. Biochimie. 2003. PMID: 12770774
-
Altered terminal glycosylation and the pathophysiology of CF lung disease.J Cyst Fibros. 2004 Aug;3 Suppl 2:95-6. doi: 10.1016/j.jcf.2004.05.021. J Cyst Fibros. 2004. PMID: 15463936
Cited by
-
Glycosylation and the cystic fibrosis transmembrane conductance regulator.Respir Res. 2001;2(5):276-9. doi: 10.1186/rr69. Epub 2001 Aug 7. Respir Res. 2001. PMID: 11686896 Free PMC article. Review.
-
Rhinovirus Infection Drives Complex Host Airway Molecular Responses in Children With Cystic Fibrosis.Front Immunol. 2020 Jul 16;11:1327. doi: 10.3389/fimmu.2020.01327. eCollection 2020. Front Immunol. 2020. PMID: 32765492 Free PMC article.
-
Differential carbohydrate recognition by Campylobacter jejuni strain 11168: influences of temperature and growth conditions.PLoS One. 2009;4(3):e4927. doi: 10.1371/journal.pone.0004927. Epub 2009 Mar 17. PLoS One. 2009. PMID: 19290056 Free PMC article.
-
Terminal glycosylation in cystic fibrosis (CF): a review emphasizing the airway epithelial cell.Glycoconj J. 2001 Sep;18(9):649-59. doi: 10.1023/a:1020815205022. Glycoconj J. 2001. PMID: 12386452 Review.
-
Modulation of expression in BEAS-2B airway epithelial cells of α-L-fucosidase A1 and A2 by Th1 and Th2 cytokines, and overexpression of α-L-fucosidase 2.Mol Cell Biochem. 2014 May;390(1-2):101-13. doi: 10.1007/s11010-014-1961-2. Epub 2014 Jan 28. Mol Cell Biochem. 2014. PMID: 24469468
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical